Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Evotec and Centogene establish drug discovery collaboration in rare genetic diseases

Aug. 27, 2018

FDA approves Takhzyro for prevention of HAE attacks

Aug. 24, 2018

AbbVie reports topline results from phase III extension study with elagolix for uterine fibroids

Aug. 23, 2018

Jupiter Orphan Therapeutics announces favorable Jotrol preclinical data

Aug. 23, 2018

Boehringer Ingelheim discovers new FFAR1 agonists

Aug. 22, 2018

Adare Pharmaceuticals describes cysteamine prodrugs

Aug. 21, 2018

Novo Nordisk reports topline PIONEER 5 results for oral semaglutide

Aug. 21, 2018

Release of phase IIa clinical data concerning a first-in-class drug for type 2 diabetes treatment

Aug. 17, 2018

FDA approves The Population Council's 1-year contraceptive Annovera

Aug. 13, 2018

Preventing fat uptake by lymphatic system could be antiobesity approach

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...